Figure 2From: Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial) Levels of interleukin 6, CRP, and PAPP-A. D0, day 0; D2, day 2; D30, day 30. Panel A: serum levels of interleukin 6. Panel B: serum levels of C-reactive protein (CRP). Panel C: serum levels of pregnancy-associated plasma protein A (PAPP-A). No significant differences between Fluvastatin group and Placebo group were detected.Back to article page